Obalon Therapeutics 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
Show More
CEO
Andrew Rasdal
Employees
2
Country
United States
ISIN
US67424L2097

Listings

0 Comments

Share your thoughts

FAQs

What is Obalon Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Obalon Therapeutics stocks are traded under the ticker 24OA.MU.
How many employees does Obalon Therapeutics have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is Obalon Therapeutics located?▼
Obalon Therapeutics operates in the Manufacturing sector.
When did Obalon Therapeutics complete a stock split?▼
The last stock split for Obalon Therapeutics was on June 16, 2021 with a ratio of 1:3.
Where is Obalon Therapeutics headquartered?▼
Obalon Therapeutics is headquartered in Carlsbad, United States.